Isothermal Nucleic Acid Amplification Technology Market Size & Share 2022 to 2028
Market Size by Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA)), by Product, by Application, by End Use & Forecast.
Report ID: GMI5251
|
Published Date: April 2022
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Isothermal Nucleic Acid Amplification Technology Market Size
Isothermal Nucleic Acid Amplification Technology Market size surpassed USD 1.3 billion in 2021 and is expected to witness an 11.8% CAGR from 2022 to 2028 due to technological developments, surging ageing population, and foreign financing for R&D. Additionally, rising demand for point-of-care (PoC) testing and growing demand for quick diagnostics will add to market expansion.
COVID-19 pandemic positively impacted isothermal nucleic acid amplification technology (INAAT) market. Since INAAT offers simple operation, rapid detection, and accurate results. As a result, it becomes more ideal for primary testing centers in urban as well as rural areas. INAAT is in high demand since PCR-based nucleic acid detection technology is time-consuming and requires specialist equipment.
Moreover, it is difficult to work with PCR in primary-level medical institutions. Antibody-based detection has limitations because of the late appearance of antibodies, that makes early diagnosis of virus difficult, whereas antigen-based detection has low sensitivity, that often result a high false-negative rate.
Isothermal nucleic acid amplification technology (INAAT) methods allow for the rapid, exponential detection of a nucleic acid target sequence. This process is not limited by the constraint of thermal cycling. Isothermal amplification, when integrated into microsystems or portable devices, improves nucleic acid-based on-site diagnostics and increases sensitivity. In addition, using different enzymatic approaches to separate the two DNA strands prior to replication, INAAT can achieve amplification in 15-16 minutes.
Isothermal Nucleic Acid Amplification Technology Market Trends
The growing incidence of infectious diseases across the globe is anticipated to drive the market expansion considerably throughout the forecast timeframe. Rise in number of infectious diseases such as influenza, HIV, tuberculosis, etc. has increased the demand for better diagnostic and treatment approaches in healthcare facilities.
According to the WHO report 2021, a total of 1.5 million people died in 2020 due to tuberculosis. Globally, tuberculosis is the 13th leading cause of death and the second leading infectious killer after COVID-19 (above HIV/AIDS). Moreover, in 2020, nearly 10 million people got infected with tuberculosis worldwide. Out of which 5.6 million were men, 3.3 million women and 1.1 million were children. Tuberculosis is present in all countries and age groups.
The conventional option to diagnose such diseases is PCR. However, with advancements in INAAT, the diagnosis can be performed quickly and in cost-effective manner. Thus, the demand of diagnostics for these diseases has surged the need for INAAT solutions. Hence, the increasing prevalence of chronic diseases has stimulated demand for INAAT diagnostic services, thereby fueling overall isothermal nucleic acid amplification technology market growth.
Isothermal Nucleic Acid Amplification Technology Market Analysis
Based on technology, the isothermal nucleic acid amplification technology market is categorized into Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Helicase-dependent Amplification (HDA) and others. The loop-mediated isothermal amplification (LAMP) segment accounted for around 47% market share in 2021. As loop-mediated isothermal amplification (LAMP) test is most widely used approach for amplification of DNA, RNA, and identification of genetically modified organisms.
Additionally, compared to PCR technology, this approach has important competitive advantages over the PCR test. The LAMP test is resistant to PCR inhibitors, making it ideal for direct sample analysis. Also, the test it is done at a constant temperature, there is no need for a thermocycler.
By product, the isothermal nucleic acid amplification technology market is bifurcated into instruments and reagents. Out of these, reagents segment accounted for around USD 950 million revenue size in 2021. The increasing number of diagnostic tests for infectious diseases has opened new growth opportunities.
Accessibility to different reagents, increased approvals of CLIA-waived tests, the continuous launch of faster, newer, and more reliable POC solutions, and rising infectious disease prevalence are also serving as important elements fueling growth avenues in the next years. Similarly, the expanding use of regents in assay development, fundamental research, and treatments, as well as repeated reagent purchases, will boost growth prospects in the forthcoming years.
Based on application, the industry is categorized into infectious disease, oncology, blood screening and others. Infectious disease is further divided into HIV, influenza, malaria, and tuberculosis. The blood screening segment is projected to witness over 12% CAGR through 2022 to 2028. Blood screening test help to understand overall blood health, metabolism, liver function, mineral levels, and various other biomarkers according to the specific tests.
Blood screening is done for various conditions such as cancer and other infections. Different technologies are used in the blood screening such as next generation sequencing, western blot assay, enzyme-linked immunosorbent assay, nucleic acid test and others. People prefer blood screening as it provides a comprehensive data of their current state of health. It can catch potential health problems in the early stages when they can be managed most effectively. Furthermore, companies are launching several blood screenings kits for diagnosis. Such scenarios contribute towards the isothermal nucleic acid amplification technology market progression.
Based on end-use, the isothermal nucleic acid amplification technology (INAAT) market is divided into hospitals, diagnostic laboratories, and others. The hospital segment accounted for over USD 628 million in 2021. Hospitals are well equipped with fully automated INAAT instruments that offer quick test results as compared to laboratories.
Besides this, the most complex and sensitive diagnostic procedures are performed in hospitals by the skilled staff to minimize the chances of error. Furthermore, with rapid growing healthcare industry, the number of hospitals has also increased thereby fueling its isothermal nucleic acid amplification technology market growth. Owing to these factors, the demand for INAAT test in hospitals is higher than the other end-use segments.
North America isothermal nucleic acid amplification technology (INAAT) industry captured over 43% market share in 2021 and is poised to grow substantially during the forthcoming years. The regional growth is attributed to advances in isothermal nucleic acid amplification technology (INAAT) and a growing preference in the region for INAAT testing over traditional diagnostic procedures.
Surging prevalence of chronic diseases in the region will also positively influence the market expansion. For instance, according to the Centers for Disease Control and Prevention (CDC) report, in the U.S. in 2018, 1,708,921 new cancer cases were reported and 599,265 people died of cancer. For every 100,000 people, 436 new cancer cases were reported and 149 people died of cancer. In addition, the increasing number of new products launches as well as the high penetration of key market competitors in North America, are further driving the market.
Isothermal Nucleic Acid Amplification Technology Market Share
Some of the key market players operating in the isothermal nucleic acid amplification technology (INAAT) industry include
These industry participants are implementing various growth strategies with continued innovations and technology improvements to sustain in the isothermal nucleic acid amplification technology market.
Some of the recent industry developments:
The isothermal nucleic acid amplification technology (INAAT) market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028, for the following segments:
Click here to Buy Section of this Report
By Technology
By Product
By Application
By End-use
The above information is provided for the following regions and countries:
By Region
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →